المؤلفون: Procopio, G, Chiuri, V E, Giordano, M, Alitto, A R, Maisano, R, Bordonaro, R, Cinieri, S, Rossetti, S, De Placido, S, Airoldi, M, Galli, L, Gasparro, D, Ludovico, G M, Guglielmini, P F, Carella, C, Nova, P, Aglietta, M, Schips, L, Beccaglia, P, Sciarra, A, Livi, L, Santini, D

المساهمون: Procopio, G, Chiuri, V E, Giordano, M, Alitto, A R, Maisano, R, Bordonaro, R, Cinieri, S, Rossetti, S, De Placido, S, Airoldi, M, Galli, L, Gasparro, D, Ludovico, G M, Guglielmini, P F, Carella, C, Nova, P, Aglietta, M, Schips, L, Beccaglia, P, Sciarra, A, Livi, L, Santini, D

مصطلحات موضوعية: Abiraterone acetate, metastatic castration-resistant prostate cancer, prospective study, real-world evidence

Relation: info:eu-repo/semantics/altIdentifier/pmid/35405438; info:eu-repo/semantics/altIdentifier/wos/WOS:000797892800017; volume:7; issue:2; firstpage:100431; journal:ESMO OPEN; http://hdl.handle.net/11573/1628868; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127748445

الاتاحة: http://hdl.handle.net/11573/1628868
https://doi.org/10.1016/j.esmoop.2022.100431

المؤلفون: Conteduca V., Di Tullio P., Allamprese R., Bruno G., Lolli C., Schepisi G., Rosano A., Giordano G., Garofoli M., Chiuri V. E., Fratino L., Zanardi E., Galli L., Massari F., Falagario U., Rescigno P., Fornarini G., Sanguedolce F., Santini D., Procopio G., Caffo O., Carrieri G., Landriscina M., De Giorgi U.

المساهمون: Conteduca, V., Di Tullio, P., Allamprese, R., Bruno, G., Lolli, C., Schepisi, G., Rosano, A., Giordano, G., Garofoli, M., Chiuri, V. E., Fratino, L., Zanardi, E., Galli, L., Massari, F., Falagario, U., Rescigno, P., Fornarini, G., Sanguedolce, F., Santini, D., Procopio, G., Caffo, O., Carrieri, G., Landriscina, M., De Giorgi, U.

Relation: info:eu-repo/semantics/altIdentifier/pmid/38347113; info:eu-repo/semantics/altIdentifier/wos/WOS:001161055500002; journal:PROSTATE CANCER AND PROSTATIC DISEASES; https://hdl.handle.net/11369/447778; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85184928462

الاتاحة: https://hdl.handle.net/11369/447778
https://doi.org/10.1038/s41391-024-00800-8

المؤلفون: Procopio G., Chiuri V. E., Giordano M., Mantini G., Maisano R., Bordonaro R., Calvani N., Facchini G., De Placido S., Airoldi M., Sbrana A., Gasparro D., Ludovico G. M., Guglielmini P., Naglieri E., Fagnani D., Aglietta M., Schips L., Beccaglia P., Sciarra A., Livi L., Santini D.

المساهمون: Procopio, G., Chiuri, V. E., Giordano, M., Mantini, G., Maisano, R., Bordonaro, R., Calvani, N., Facchini, G., De Placido, S., Airoldi, M., Sbrana, A., Gasparro, D., Ludovico, G. M., Guglielmini, P., Naglieri, E., Fagnani, D., Aglietta, M., Schips, L., Beccaglia, P., Sciarra, A., Livi, L., Santini, D.

مصطلحات موضوعية: abiraterone acetate, effectivene, metastatic castration-resistant prostate cancer, prospective study, real-world study

Relation: info:eu-repo/semantics/altIdentifier/pmid/33193831; info:eu-repo/semantics/altIdentifier/wos/WOS:000590528800001; volume:12; numberofpages:13; journal:THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY; http://hdl.handle.net/11573/1461421; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85094641800

الاتاحة: http://hdl.handle.net/11573/1461421
https://doi.org/10.1177/1758835920968725

المؤلفون: Mennitto, A., Verzoni, E., Cognetti, F., Miceli, R., Milella, M., Mosca, A., Chiuri, V. E., Bearz, A., Morelli, F., Ortega, C., Atzori, F., Donini, M., Claps, M., Guadalupi, V., Sepe, P., Cappelletti, V., de Braud, F. G., Procopio, G.

المصدر: Expert Review of Clinical Pharmacology ; volume 14, issue 2, page 261-268 ; ISSN 1751-2433 1751-2441

الاتاحة: http://dx.doi.org/10.1080/17512433.2021.1879639
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1879639

المؤلفون: Conteduca V., Caffo O., Scarpi E., Sepe P., Galli L., Fratino L., Maines F., Chiuri V. E., Santoni M., Zanardi E., Massari F., Toma I., Lolli C., Schepisi G., Sbrana A., Kinspergher S., Cursano M. C., Casadei C., Modonesi C., Santini D., Procopio G., De Giorgi U.

المساهمون: Conteduca V., Caffo O., Scarpi E., Sepe P., Galli L., Fratino L., Maines F., Chiuri V.E., Santoni M., Zanardi E., Massari F., Toma I., Lolli C., Schepisi G., Sbrana A., Kinspergher S., Cursano M.C., Casadei C., Modonesi C., Santini D., Procopio G., De Giorgi U.

مصطلحات موضوعية: Abiraterone, Androgen deprivation therapy, Autoimmunity, Enzalutamide, Prognosi, Prostate cancer

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000549439800001; volume:9; issue:6; firstpage:1; lastpage:12; numberofpages:12; journal:JOURNAL OF CLINICAL MEDICINE; https://hdl.handle.net/11585/908903; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114283024; https://www.mdpi.com/2077-0383/9/6/1950

الاتاحة: https://hdl.handle.net/11585/908903
https://doi.org/10.3390/jcm9061950
https://www.mdpi.com/2077-0383/9/6/1950

المؤلفون: Conteduca, V., Caffo, O., Galli, L., Maugeri, A., Scarpi, E., Maines, F., Chiuri, V., Lolli, C., Kinspergher, S., Schepisi, G., Santoni, M., Santini, D., Fratino, L., Burgio, S.L., Salvi, S., Menna, C., De Giorgi, U.

المصدر: Annals of Oncology ; volume 28, page v39-v40 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdx363.056
https://api.elsevier.com/content/article/PII:S0923753420376341?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753420376341?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx363.056/19938637/mdx363.056.pdf

المؤلفون: Saad, F., Thiery-Vuillemin, A., Wiechno, P., Alekseev, B., Sala, N., Jones, R., Kocak, I., Chiuri, V. E., Jassem, J., Fléchon, A., Redfern, C., Kang, J., Burgents, J., Gresty, C., Degboe, A., Clarke, Noel W

المساهمون: Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

Relation: https://dx.doi.org/10.1016/s1470-2045(22)00498-3; Saad F, Thiery-Vuillemin A, Wiechno P, Alekseev B, Sala N, Jones R, et al. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial. The Lancet Oncology. 2022 Sep 2. PubMed PMID: 36063830. Epub 2022/09/06. eng.; http://hdl.handle.net/10541/625615; Lancet Oncology

الاتاحة: http://hdl.handle.net/10541/625615
https://doi.org/10.1016/s1470-2045(22)00498-3

المؤلفون: Procopio, G., Porcu, L., Grassi, P., De Giorgi, U., Galli, L., Caffo, O., Boccardo, F., Facchini, G., De Vincenzo, F., Zaniboni, A., Chiuri, V., Fratino, L., Santini, D., Adamo, V., De Vivo, R., Di Nota, A., Messina, C., Ricotta, R., de Braud, F., Verzoni, E.

المصدر: Annals of Oncology ; volume 26, page vi59 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdv341.21
https://api.elsevier.com/content/article/PII:S0923753419533853?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419533853?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/26/suppl_6/vi59/6681215/mdv341.21.pdf

المؤلفون: Caffo O., Facchini G., Biasco E., Ferrau F., Morelli F., Donini M., Buttigliero C., Calvani N., Guida A., Chiuri V. E., Basso U., Mucciarini C., Conteduca V., Rossetti S., Veccia A., Maines F., Kinspergher S., Giorgi U. D.

المساهمون: Caffo O., Facchini G., Biasco E., Ferrau F., Morelli F., Donini M., Buttigliero C., Calvani N., Guida A., Chiuri V.E., Basso U., Mucciarini C., Conteduca V., Rossetti S., Veccia A., Maines F., Kinspergher S., Giorgi U.D.

مصطلحات موضوعية: castration-resistant prostate cancer, cyclophosphamide, fourth line, third line

Relation: info:eu-repo/semantics/altIdentifier/pmid/30887825; info:eu-repo/semantics/altIdentifier/wos/WOS:000468121800007; volume:15; issue:10; firstpage:1115; lastpage:1123; numberofpages:9; journal:FUTURE ONCOLOGY; http://hdl.handle.net/2318/1706880; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064229575; http://www.futuremedicine.com/loi/fon

الاتاحة: http://hdl.handle.net/2318/1706880
https://doi.org/10.2217/fon-2018-0715
http://www.futuremedicine.com/loi/fon

المؤلفون: Conteduca V., Caffo O., Lolli C., Aieta M., Scarpi E., Bianchi E., Maines F., Schepisi G., Salvi S., Massari F., Carrozza F., Veccia A., Chiuri V. E., Campadelli E., Facchini G., De Giorgi U.

المساهمون: Conteduca, V., Caffo, O., Lolli, C., Aieta, M., Scarpi, E., Bianchi, E., Maines, F., Schepisi, G., Salvi, S., Massari, F., Carrozza, F., Veccia, A., Chiuri, V. E., Campadelli, E., Facchini, G., De Giorgi, U.

مصطلحات موضوعية: abiraterone, castration-resistant prostate cancer, outcome, PSA surge, treatment response

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000400976900009; volume:77; issue:9; firstpage:1012; lastpage:1019; numberofpages:8; journal:THE PROSTATE; http://hdl.handle.net/11369/407982; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85018635498

الاتاحة: http://hdl.handle.net/11369/407982
https://doi.org/10.1002/pros.23357

المؤلفون: Ciccarese M., Fabi A., Moscetti L., Cazzaniga M. E., Petrucelli L., Forcignano R., Lupo L. I., De Matteis E., Chiuri V. E., Cairo G., Febbraro A., Giordano G., Giampaglia M., Bilancia D., La Verde N., Maiello E., Morritti M., Giotta F., Lorusso V., Latorre A., Scavelli C., Romito S., Cusmai A., Palmiotti G., Surico G.

المساهمون: Ciccarese, M., Fabi, A., Moscetti, L., Cazzaniga, M. E., Petrucelli, L., Forcignano, R., Lupo, L. I., De Matteis, E., Chiuri, V. E., Cairo, G., Febbraro, A., Giordano, G., Giampaglia, M., Bilancia, D., La Verde, N., Maiello, E., Morritti, M., Giotta, F., Lorusso, V., Latorre, A., Scavelli, C., Romito, S., Cusmai, A., Palmiotti, G., Surico, G.

مصطلحات موضوعية: Breast cancer, Dose intensity, Everolimu, Real-world population, Side effect, Adult, Aged, 80 and over, Androstadiene, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Disease-Free Survival, Drug-Related Side Effects and Adverse Reaction, Female, Human, Italy, Middle Aged, Neoplasm Staging, Receptor, ErbB-2, Receptors, Estrogen, Progesterone, Stomatitis

Relation: info:eu-repo/semantics/altIdentifier/pmid/28353061; info:eu-repo/semantics/altIdentifier/wos/WOS:000401465200018; volume:163; issue:3; firstpage:587; lastpage:594; numberofpages:8; journal:BREAST CANCER RESEARCH AND TREATMENT; http://hdl.handle.net/11369/393423; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85016103585

الاتاحة: http://hdl.handle.net/11369/393423
https://doi.org/10.1007/s10549-017-4213-9

المؤلفون: Clarke, Noel W, Wiechno, P, Alekseev, B, Sala, N, Jones, R, Kocak, I, Chiuri, V, Jassem, J, Fléchon, A, Redfern, C, Goessl, C, Burgents, J, Kozarski, R, Hodgson, D, Learoyd, M, Saad, F

المساهمون: The Christie and Salford Royal Hospitals, Manchester, UK

Relation: Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial. 2018, Lancet Oncol; http://hdl.handle.net/10541/621079; The Lancet Oncology

الاتاحة: http://hdl.handle.net/10541/621079
https://doi.org/10.1016/S1470-2045(18)30365-6

المؤلفون: Lolli C., Caffo O., Scarpi E., Aieta M., Conteduca V., Maines F., Bianchi E., Massari F., Veccia A., Chiuri V. E., Facchini G., De Giorgi U.

المساهمون: Lolli, C., Caffo, O., Scarpi, E., Aieta, M., Conteduca, V., Maines, F., Bianchi, E., Massari, F., Veccia, A., Chiuri, V. E., Facchini, G., De Giorgi, U.

مصطلحات موضوعية: Abiraterone, CRPC, Prognostic factor, Prostate cancer, PSA, Systemic immune-inflammation index

Relation: info:eu-repo/semantics/altIdentifier/pmid/27790145; info:eu-repo/semantics/altIdentifier/wos/WOS:000385060300001; volume:7; issue:OCT; firstpage:376; journal:FRONTIERS IN PHARMACOLOGY; http://hdl.handle.net/11369/408104; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84995404248

الاتاحة: http://hdl.handle.net/11369/408104
https://doi.org/10.3389/fphar.2016.00376

المؤلفون: Conteduca V., Caffo O., Derosa L., Veccia A., Petracci E., Chiuri V. E., Santoni M., Santini D., Fratino L., Maines F., Testoni S., De Giorgi U.

المساهمون: Conteduca, V., Caffo, O., Derosa, L., Veccia, A., Petracci, E., Chiuri, V. E., Santoni, M., Santini, D., Fratino, L., Maines, F., Testoni, S., De Giorgi, U.

مصطلحات موضوعية: abiraterone acetate, cardiovascular event, castration-resistant prostate cancer, metabolic syndrome, survival

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000358494600010; volume:75; issue:12; firstpage:1329; lastpage:1338; numberofpages:10; journal:THE PROSTATE; http://hdl.handle.net/11369/408056; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84937510693

الاتاحة: http://hdl.handle.net/11369/408056
https://doi.org/10.1002/pros.23014

المؤلفون: Tinelli, A, Malvasi, A, Lorusso, V, Chiuri, V. E, Cinieri, S, Vergara, D, Martignago, R, Vergari, U, Pisano, M, Leo G

المساهمون: Tinelli, A, Malvasi, A, Lorusso, V, Chiuri, V. E, Cinieri, S, Vergara, D, Martignago, R, Vergari, U, Pisano, M, Leo, G

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/isbn/978-160741814-6; info:eu-repo/semantics/altIdentifier/wos/WOS:000276105000006; ispartofbook:DNA: Fingerprinting, Sequencing and Chips; firstpage:119; lastpage:132; numberofpages:14; http://hdl.handle.net/11587/421243; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-77950427140

الاتاحة: http://hdl.handle.net/11587/421243

المؤلفون: Bracarda S, Gernone A, Gasparro D, Marchetti P, Gianni L, Bortolus R, Fratino L, Zagonel V, Mazzanti R, Messina C, Tucci M, Carteni G, Pinto C, Fornarini G, Mattioli R, Procopio G, Chiuri V, Scotto T, Dondi D, Di Lorenzo G., BOCCARDO, FRANCESCO

المساهمون: Bracarda, S, Gernone, A, Gasparro, D, Marchetti, P, Gianni, L, Bortolus, R, Fratino, L, Zagonel, V, Mazzanti, R, Messina, C, Tucci, M, Boccardo, Francesco, Carteni, G, Pinto, C, Fornarini, G, Mattioli, R, Procopio, G, Chiuri, V, Scotto, T, Dondi, D, Di Lorenzo, G.

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/pmid/24295376; info:eu-repo/semantics/altIdentifier/wos/WOS:000337938300013; firstpage:525; lastpage:534; numberofpages:10; journal:FUTURE ONCOLOGY; http://hdl.handle.net/11567/694792; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84903150063

الاتاحة: http://hdl.handle.net/11567/694792
https://doi.org/10.2217/fon.13.256

المؤلفون: Ciccarese, M, Fabi, A, Moscetti, L, Cazzaniga, M, Petrucelli, L, Forcignanò, R, Lupo, L, De Matteis, E, Chiuri, V, Cairo, G, Febbraro, A, Giordano, G, Giampaglia, M, Bilancia, D, La Verde, N, Maiello, E, Morritti, M, Giotta, F, Lorusso, V, Latorre, A, Scavelli, C, Romito, S, Cusmai, A, Palmiotti, G, Surico, Ciccarese M, Fabi A, Moscetti L, Cazzaniga M, Petrucelli L, Forcignanò R, Lupo LI, De Matteis E, Chiuri VE, Cairo G, Febbraro A, Giordano G, Giampaglia M, Bilancia D, La Verde N, Maiello E, Morritti M, Giotta F, Lorusso V, Latorre A, Scavelli C, Romito S, Cusmai A, Palmiotti G

مصطلحات الفهرس: everolimus and exemestane (EVE/EXE), advanced breast cancer (ABC), multicenter Italian experience, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10281/281985
info:eu-repo/semantics/altIdentifier/pmid/28353061
info:eu-repo/semantics/altIdentifier/wos/WOS:000401465200018
volume:163
issue:3
firstpage:587
lastpage:594
numberofpages:8
journal:BREAST CANCER RESEARCH AND TREATMENT

المؤلفون: Lorusso V, Cinieri S, Giampaglia M, Ciccarese M, Tinelli A, Chiuri V, Manca C, Silvestris N, Gasparini G, Colucci G

المساهمون: Lorusso, V, Cinieri, S, Giampaglia, M, Ciccarese, M, Tinelli, A, Chiuri, V, Manca, C, Silvestris, N, Gasparini, G, Colucci, G

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000279292600013; firstpage:1; lastpage:5; numberofpages:5; journal:THE BREAST; http://hdl.handle.net/11570/3234472; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-77953359063

الاتاحة: http://hdl.handle.net/11570/3234472

المؤلفون: Giampaglia M., Chiuri V. E., Tinelli A., De Laurentiis M., Silvestris N., Lorusso V.

المساهمون: Giampaglia, M., Chiuri, V. E., Tinelli, A., De Laurentiis, M., Silvestris, N., Lorusso, V.

مصطلحات موضوعية: Anthracycline, Breast cancer, Chemotherapy, EGFR, HER2, Lapatinib, Taxane, Trastuzumab, Tyrosine-kinase inhibitor, Administration, Oral, Antibodies, Monoclonal, Humanized, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Female, Forecasting, Human, Lymphatic Metastasi, Neoadjuvant Therapy, Protein-Tyrosine Kinase, Quinazoline, Receptor, ErbB-2

Relation: info:eu-repo/semantics/altIdentifier/pmid/21129615; info:eu-repo/semantics/altIdentifier/wos/WOS:000285825200013; volume:36; issue:3; firstpage:S72; lastpage:S79; journal:CANCER TREATMENT REVIEWS; http://hdl.handle.net/11586/250880; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-78649729937

الاتاحة: http://hdl.handle.net/11586/250880
https://doi.org/10.1016/S0305-7372(10)70024-4

المؤلفون: Lorusso V., Cinieri S., Giampaglia M., Ciccarese M., Tinelli A., Chiuri V., Manca C., Silvestris N., Gasparini G., Colucci G.

المساهمون: Lorusso, V., Cinieri, S., Giampaglia, M., Ciccarese, M., Tinelli, A., Chiuri, V., Manca, C., Silvestris, N., Gasparini, G., Colucci, G.

مصطلحات موضوعية: Administration, Capecitabine, Metastatic breast cancer, Vinorelbine, Oral, Adult, Aged, Antineoplastic Agent, Breast Neoplasm, Combined Modality Therapy, Deoxycytidine, Drug Therapy, Combination, Female, Fluorouracil, Human, Infusions, Intravenou, Middle Aged, Retrospective Studie, Treatment Outcome, Vinblastine

Relation: info:eu-repo/semantics/altIdentifier/pmid/20167491; info:eu-repo/semantics/altIdentifier/wos/WOS:000279292600013; volume:19; issue:3; firstpage:214; lastpage:218; numberofpages:5; journal:THE BREAST; http://hdl.handle.net/11586/250890; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-77953359063

الاتاحة: http://hdl.handle.net/11586/250890
https://doi.org/10.1016/j.breast.2010.01.015